loading
전일 마감가:
$7.73
열려 있는:
$7.72
하루 거래량:
214.01K
Relative Volume:
1.29
시가총액:
$163.10M
수익:
$66.59M
순이익/손실:
$-104.93M
주가수익비율:
-1.5455
EPS:
-4.95
순현금흐름:
$-96.48M
1주 성능:
+16.08%
1개월 성능:
+6.55%
6개월 성능:
+47.68%
1년 성능:
-47.89%
1일 변동 폭
Value
$7.49
$7.89
1주일 범위
Value
$6.435
$8.11
52주 변동 폭
Value
$4.09
$15.92

Enanta Pharmaceuticals Inc Stock (ENTA) Company Profile

Name
명칭
Enanta Pharmaceuticals Inc
Name
전화
617 607 0800
Name
주소
4 KINGSBURY AVENUE, WATERTOWN, MA
Name
직원
131
Name
트위터
@EnantaPharma
Name
다음 수익 날짜
2025-02-10
Name
최신 SEC 제출 서류
Name
ENTA's Discussions on Twitter

ENTA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ENTA
Enanta Pharmaceuticals Inc
7.63 148.78M 66.59M -104.93M -96.48M -4.95
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
468.51 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
555.47 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
324.96 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
574.44 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.06 27.29B 3.81B -644.79M -669.77M -6.24

Enanta Pharmaceuticals Inc Stock (ENTA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-08-09 다운그레이드 JP Morgan Neutral → Underweight
2023-08-08 다운그레이드 Jefferies Buy → Hold
2022-12-09 개시 H.C. Wainwright Buy
2022-07-06 업그레이드 Evercore ISI In-line → Outperform
2022-06-01 업그레이드 Evercore ISI Underperform → In-line
2021-10-07 개시 Jefferies Buy
2021-09-09 개시 SVB Leerink Mkt Perform
2021-01-29 업그레이드 JP Morgan Underweight → Neutral
2020-11-24 개시 Evercore ISI Underperform
2020-08-28 재개 ROTH Capital Buy
2020-08-26 개시 Piper Sandler Overweight
2020-07-27 업그레이드 JMP Securities Mkt Perform → Mkt Outperform
2020-03-17 업그레이드 Robert W. Baird Neutral → Outperform
2019-11-22 다운그레이드 JMP Securities Mkt Outperform → Mkt Perform
2019-09-26 다운그레이드 JP Morgan Neutral → Underweight
2019-05-24 개시 Wolfe Research Outperform
2019-04-23 업그레이드 Berenberg Hold → Buy
2018-12-13 개시 Berenberg Hold
2018-06-06 개시 ROTH Capital Buy
2018-02-08 다운그레이드 JP Morgan Overweight → Neutral
2018-01-02 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2017-11-21 재확인 RBC Capital Mkts Outperform
2017-09-15 개시 RBC Capital Mkts Outperform
2017-07-11 업그레이드 JMP Securities Mkt Perform → Mkt Outperform
2016-04-28 다운그레이드 JMP Securities Mkt Outperform → Mkt Perform
2016-02-09 재확인 Barclays Underweight
2015-10-23 다운그레이드 Barclays Equal Weight → Underweight
2015-10-23 업그레이드 JMP Securities Mkt Perform → Mkt Outperform
모두보기

Enanta Pharmaceuticals Inc 주식(ENTA)의 최신 뉴스

pulisher
Jul 20, 2025

What analysts say about Enanta Pharmaceuticals Inc. stockStrong return on investment - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 20, 2025

What drives Enanta Pharmaceuticals Inc. stock priceFree Investment Case Studies - Autocar Professional

Jul 20, 2025
pulisher
Jul 19, 2025

Is Enanta Pharmaceuticals Inc. a good long term investmentSuperior profit margins - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

Enanta Pharmaceuticals Inc. Stock Analysis and ForecastDynamic profit opportunities - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

why enanta pharmaceuticals inc. stock attracts strong analyst attentionShort Term Risk Controlled Alerts - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Will Enanta Pharmaceuticals Inc. stock benefit from interest rate changesFast Growing Stocks - Newser

Jul 18, 2025
pulisher
Jul 16, 2025

Enanta Pharmaceuticals to Participate in Baird’s Biotech Discovery Series - BioSpace

Jul 16, 2025
pulisher
Jul 16, 2025

how enanta pharmaceuticals inc. stock performs during market volatilityFree Smart Investment Opportunities - Newser

Jul 16, 2025
pulisher
Jul 16, 2025

What makes Enanta Pharmaceuticals Inc. stock price move sharplyBreakout Momentum Stocks - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

How Enanta Pharmaceuticals Inc. stock performs during market volatilityFree Investment Community - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Enanta Pharmaceuticals Inc. stock attracts strong analyst attentionVolume Spike Monitors - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

(ENTA) On The My Stocks Page - news.stocktradersdaily.com

Jul 12, 2025
pulisher
Jul 10, 2025

Enanta Pharmaceuticals Insider Buyers Net US$65k Despite 11% Stock Decline - simplywall.st

Jul 10, 2025
pulisher
Jun 21, 2025

(ENTA) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Jun 21, 2025
pulisher
Jun 14, 2025

Enanta Pharmaceuticals’ SWOT analysis: stock shifts focus to immunology amid RSV progress - Investing.com Nigeria

Jun 14, 2025
pulisher
Jun 13, 2025

AbbVie Secures FDA Approval to Expand Mavyret’s Label - Yahoo Finance

Jun 13, 2025
pulisher
Jun 12, 2025

ENTA’s Market Quandary: Decoding the Ups and Downs of 2023 - investchronicle.com

Jun 12, 2025
pulisher
Jun 11, 2025

FDA Expands AbbVie's Mavyret Label To Include Acute Hepatitis C Treatment (CORRECTED) - Benzinga

Jun 11, 2025
pulisher
Jun 11, 2025

FDA Expands AbbVie's Mavyret Label To Include Acute Hepatitis C Treatment (CORRECTED) - Benzinga

Jun 11, 2025
pulisher
Jun 11, 2025

AbbVie wins FDA nod for Mavyret label expansion (ABBV:NYSE) - Seeking Alpha

Jun 11, 2025
pulisher
Jun 11, 2025

Enanta Pharmaceuticals' Partner AbbVie Receives U.S. FDA Approva - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Enanta Pharmaceuticals’ Partner AbbVie Receives U.S. FDA Approval of an Expanded Indication for MAVYRET® (glecaprevir/pibrentasvir) as the First and Only Treatment for People with Acute Hepatitis C Virus - Yahoo Finance

Jun 11, 2025
pulisher
Jun 10, 2025

(ENTA) Proactive Strategies - news.stocktradersdaily.com

Jun 10, 2025
pulisher
Jun 04, 2025

Enanta Pharmaceuticals (NASDAQ:ENTA) Given New $24.00 Price Target at JMP Securities - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Enanta Pharma (ENTA) Receives Target Price Boost from JMP Securi - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Enanta (ENTA) Price Target Raised as Key Clinical Results Antici - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Enanta (ENTA) Price Target Raised as Key Clinical Results Anticipated | ENTA Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Citizens JMP raises Enanta Pharmaceuticals stock price target to $24 By Investing.com - Investing.com UK

Jun 03, 2025
pulisher
May 27, 2025

Enanta Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - BioSpace

May 27, 2025
pulisher
May 27, 2025

Enanta Pharmaceuticals to Present at the Jefferies Global Health - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Enanta Pharmaceuticals to Present at the Jefferies Global Healthcare Conference | ENTA Stock News - GuruFocus

May 27, 2025

Enanta Pharmaceuticals Inc (ENTA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$21.82
price up icon 0.67%
$35.83
price up icon 0.55%
$103.39
price up icon 0.67%
$26.32
price up icon 0.15%
$109.96
price up icon 0.27%
biotechnology ONC
$294.68
price up icon 0.93%
자본화:     |  볼륨(24시간):